Sangamo Therapeutics, Inc. (SGMO) Stock Price, News, Quote & History - Yahoo Finance (2024)

0&&s)if(o){var r,a=(r=e.newCount)>99;s.textContent=a?"99+":r+"",null===(t=s.parentElement)||void 0===t||t.classList.add(zt)}else s.style.display="block"},m=function(){d.refreshPanel().then(h).then(ee).catch((function(){}))};e.addEventListener("close-all-menus",(function(){xe(c)||u()})),c&&(m(),setInterval((function(){m()}),3e5),o?l&&l.addEventListener("mouseenter",(function(){p(),null==t||t.show()})):c.addEventListener("mouseenter",(function(){p(),null==t||t.show()})),c.addEventListener("mouseleave",(function(){u(),null==t||t.hide()}))),e.addElementListener(i,"click",(function(){Q("ybar","notification","",{elm:"btn",elmt:"block"===(null==s?void 0:s.style.display)?"newalert":"",subsec:"notification",itc:"1"})})),r&&Ee(e,r,"ybar","notification",{elm:"expand",subsec:"notifications",itc:"2"}),e.addElementListener(a,"focusin",(function(){i&&(i.checked=!0),null==a||a.classList.add("ybarMenuOpen")})),e.addElementListener(a,"focusout",u),e.addElementListener(n.tooltipContainer,"focusin",(function(){null==t||t.show()})),e.addElementListener(n.tooltipContainer,"focusout",(function(){null==t||t.hide()}));var f=e.getConfig().device,v=document.getElementById("ybar");v&&v.classList.contains("ybar-ytheme-crunch")&&(Qt=0);var y=new RegExp("[?&]notifications=1(&|#|$)");"desktop"===f&&i&&y.test(window.location.search)&&(i.checked=!0)};ye("ybar-mod-notification",(function(e){var n={isUH3:"crunch"===e.getConfig().ytheme,notifContainer:document.getElementById("notification-container"),notifBadge:document.getElementById("notif-badge"),notifMenu:document.getElementById("ybarNotificationMenu"),notifMenuOpener:document.querySelector("#ybarNotificationMenu + label"),notifDropdown:document.getElementById("notifDropdownContainer"),tooltipContainer:document.querySelector(".".concat(Ft)),notifLabel:document.querySelector(".".concat(Gt))};no(e,n)}))}()}};

NasdaqGS - Delayed Quote • USD

0.5917 +0.0063 (+1.08%)

At close: June 6 at 4:00 PM EDT

0.5917 0.00 (0.00%)

After hours: June 6 at 7:46 PM EDT

Key Events

Line

Candle

Baseline

Mountain

Bar

Advanced Chart

Loading Chart for SGMO

9/21 12:03 PM

DELL

Date
Close
Open
High
Low
Volume

• Previous Close 0.5854
• Open 0.5792
• Bid 0.5548 x 300
• Ask 0.5950 x 600
• Day's Range 0.5611 - 0.6100
• 52 Week Range 0.2900 - 1.6700
• Volume 1,188,825
• Avg. Volume 1,895,739
• Market Cap (intraday) 122.784M
• Beta (5Y Monthly) 1.35
• PE Ratio (TTM) --
• EPS (TTM) -1.8800
• Earnings Date Aug 6, 2024 - Aug 12, 2024
• Forward Dividend & Yield --
• Ex-Dividend Date --
• 1y Target Est 3.50

Sangamo Therapeutics, Inc., a clinical-stage genomic medicine company, focuses on translating science into medicines that transform the lives of patients and families afflicted with serious diseases in the United States. The company's clinical-stage product candidates are ST-920, a gene therapy product candidate, which is in Phase 1/2 clinical study for the treatment of Fabry disease; TX200, a chimeric antigen receptor engineered regulatory T cell (CAR-Treg) therapy product candidate that is in Phase 1/2 clinical study for the prevention of immune-mediated rejection in HLA-A2 mismatched kidney transplantation; SB-525, a gene therapy product candidate, which is in Phase 3 clinical trial for the treatment of moderately severe to severe hemophilia A; BIVV003, a zinc finger nuclease gene-edited cell therapy product candidate that is in Phase 1/2 PRECIZN-1 clinical study for the treatment of sickle cell disease. Its preclinical development products focus on CAR-Treg cell therapies for autoimmune disorders and genome engineering for neurological diseases. Sangamo Therapeutics, Inc. has collaborative and strategic partnerships with Biogen MA, Inc.; Kite Pharma, Inc.; Pfizer Inc.; Sanofi S.A.; Novartis Institutes for BioMedical Research, Inc.; Shire International GmbH; Dow AgroSciences LLC; Sigma-Aldrich Corporation; Genentech, Inc.; Open Monoclonal Technology, Inc.; and California Institute for Regenerative Medicine. The company was formerly known as Sangamo BioSciences, Inc. and changed its name to Sangamo Therapeutics, Inc. in January 2017. Sangamo Therapeutics, Inc. was incorporated in 1995 and is headquartered in Richmond, California.

www.sangamo.com

405

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Biotechnology

Industry

More about Sangamo Therapeutics, Inc.

Recent News: SGMO

View More

All SEC Filings

Corporate Changes & Voting Matters

Periodic Financial Reports

Proxy Statements

Tender Offer/Acquisition Reports

Offering Registrations

See Also

Sangamo Therapeutics Inc (SGMO) Stock Price & News - Google FinanceSangamo Therapeutics - SGMO - Stock Price TodaySangamo Therapeutics, Inc. (SGMO) Stock Price, Quote & News - Stock Analysis

View More

Performance Overview: SGMO

Trailing total returns as of 6/6/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

SGMO

9.57%

S&P 500

12.23%

1-Year Return

SGMO

48.99%

S&P 500

25.25%

3-Year Return

SGMO

94.57%

S&P 500

26.55%

5-Year Return

SGMO

93.64%

S&P 500

89.41%

Compare To: SGMO

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

SGMOSangamo Therapeutics, Inc.

0.5917

+1.08%

Mkt Cap 122.784M

Industry Biotechnology

KPTIKaryopharm Therapeutics Inc.

0.9729

-2.16%

Mkt Cap 121.239M

Industry Biotechnology

GOSSGossamer Bio, Inc.

0.6000

+4.71%

Mkt Cap 135.731M

Industry Biotechnology

MREOMereo BioPharma Group plc

3.4400

-1.71%

Mkt Cap 490.953M

Industry Biotechnology

ATRAAtara Biotherapeutics, Inc.

0.5691

-1.71%

Mkt Cap 69.721M

Industry Biotechnology

RIGLRigel Pharmaceuticals, Inc.

0.9597

-1.79%

Mkt Cap 171.407M

Industry Biotechnology

DTILPrecision BioSciences, Inc.

12.54

-3.61%

Mkt Cap 86.847M

Industry Biotechnology

CARACara Therapeutics, Inc.

0.6421

-7.62%

Mkt Cap 38.005M

Industry Biotechnology

NKTRNektar Therapeutics

1.3900

-2.11%

Mkt Cap 261.308M

Industry Biotechnology

BLUEbluebird bio, Inc.

0.9145

-3.48%

Mkt Cap 182.623M

Industry Biotechnology

VYGRVoyager Therapeutics, Inc.

8.48

-2.53%

Mkt Cap 461.258M

Industry Biotechnology

Statistics: SGMO

View More

Valuation Measures

As of 6/6/2024

• Market Cap

  122.78M

• Enterprise Value

  99.18M

• Trailing P/E

  --

• Forward P/E

  --

• PEG Ratio (5yr expected)

  --

• Price/Sales (ttm)

  5.60

• Price/Book (mrq)

  2.17

• Enterprise Value/Revenue

  5.29

• Enterprise Value/EBITDA

  --

Financial Highlights

Profitability and Income Statement

• Profit Margin

  0.00%

• Return on Assets (ttm)

  -49.47%

• Return on Equity (ttm)

  -167.24%

• Revenue (ttm)

  18.76M

• Net Income Avi to Common (ttm)

  -328.05M

• Diluted EPS (ttm)

  -1.8800

Balance Sheet and Cash Flow

• Total Cash (mrq)

  54.42M

• Total Debt/Equity (mrq)

  54.35%

• Levered Free Cash Flow (ttm)

  -120.99M

View More

Research Analysis: SGMO

View More

View More

People Also Watch

EDIT Editas Medicine, Inc.

5.43

-3.04%

NTLA Intellia Therapeutics, Inc.

22.95

-0.61%

BLUE bluebird bio, Inc.

0.9145

-3.48%

ALNY Alnylam Pharmaceuticals, Inc.

149.30

-1.82%

NKTR Nektar Therapeutics

1.3900

-2.11%

QURE uniQure N.V.

5.31

-2.21%

CLLS Cellectis S.A.

2.6700

-2.91%

FOLD Amicus Therapeutics, Inc.

10.27

-2.00%

SRPT Sarepta Therapeutics, Inc.

117.44

-1.96%

TGTX TG Therapeutics, Inc.

15.81

-4.36%

BMRN BioMarin Pharmaceutical Inc.

80.85

+1.48%

PBYI Puma Biotechnology, Inc.

3.5600

-2.73%

EXEL Exelixis, Inc.

22.18

+1.00%

RGNX REGENXBIO Inc.

13.76

-5.23%

FATE Fate Therapeutics, Inc.

3.8000

+1.06%

ACAD ACADIA Pharmaceuticals Inc.

15.30

-0.13%